Plasma levels of glucose, insulin and glucagon were measured at various time intervals after pancreatic duct ligation (PDL) 
INTRODUCTION
Modifications in islet cell mass are demonstrated to be largely responsible for the glycemic disturbances, and especially the hyperglycemia, in noninsulin-dependent diabetic (NIDDM) GK rats, Ill spontaneously diabetic Chinese hamsters I21 and secondary to pancreatitis. TM or fibro-calculouspancreatic diabetes (FCPD) . I41 Over the past two decades, hyperglycemia-related hyperglucagonemia has also been observed in NIDDM patients, streptozotocin rats [6] and alloxan-diabetic dogs, [7] *Corresponding author. Tel./Fax: + 33(0)561 085 636, e-mail: catala@lmtg.ups-tlse.fr 101 as well as in chronic pancreatitis. I81 Glucagon is found to cause the hyperglycemia in diabetic diseases by increasing hepatic glucose output (HGO), which stimulates gluconeogenesis in fasting NIDDM. I91 Moreover, the hyperglucagonemia of diabetes may be accounted for by defects in primary A-and B-cells I11 as well as by an impaired insulin secretion.
In a previous report, I11 we described the noninsulin-dependent diabetogenic effects following pancreatic duct ligation (PDL) in the rabbit. I11 The main short-term glycemic disorders were a transient hyperglycemia and glucose intolerance I11 concomitant with dissociation I121 and regeneration of the Langerhans islet cells during the first month. [13] The destruction of the islet architecture led to morphological and metabolic changes [4, 151 notably at the time of minimum mass of B-cells (day 30) . By the 5th and 35th days, the impairment in insulin secretion in the isolated perfused pancreas is characterized by loss of the early peak insulin release in response to glucose stimulation and the abolition of the potentiating effect of glucose on the arginineinduced secretion. I161 These effects resemble those noted in NIDDM, I171 FCPD, I81 acute pancreatitis, I191 and adult GK rats. I21 The present study was designed to: (1) characterize glycemia and glucose tolerance after long-term pancreatic duct ligation, to discern relationships between glucose and insulin, glucose and/or glucagon in plasma, and correlations of plasma levels of these two hormones with pancreatic stores (2) glucose (r=-0.94, p<0.001), but there was a positive correlation between glucose and glucagon (r 0.95, p < 0.001).
The evolution of pancreatic insulin and glucagon stores is illustrated in Figure 2 Figure 6 . In the C group, immunostained cells for glucagon were found mainly on the periphery of the islets (Fig. 6a) . After PDL, the marked A-cell immunoreactivity enabled us to localize the numerous changes in the long-term recasting pancreas. At 180 days (Fig. 6b) (Fig. 6c) . Enlarged homologous and heterologous A-cell areas were distributed inside the fibrous tissue, which was itself surrounded by adipose tissue at 450 days (Fig. 6d) .
DISCUSSION
Pancreatic duct ligation (PDL) in our rabbits induced atrophy and fibrotic replacement of the pancreatic acini, I121 consistent with most of the effects produced by either duct ligation or occlusion in various species. [23] [24] [25] However, its influence on the endocrine system was less in accord with previous reports. [26, 271 To our knowledge, the rabbit is the only laboratory animal that possesses a single pancreatic duct, separated by 40 cm from the bile duct. [28] Its ligation leads to neither severe nutritional disorders nor obesity, I291 which may be accounted for by compensatory digestive processes induced by microorganisms I301 or intestinal mucosal enzyme activities, which are thought to operate after PDL, I311 in patients with cystic fibrosis [32] and those with chronic pancreatic insufficiency associated with diabetes mellitus. I331 In fact in rabbits, long-term pancreatic duct ligation induces no visible pathological signs, apart from a chronic and progressive diabetogenic state leading to irreversible pathology. However, our findings differed from those of Hepner et al. [ 341 who found blood glucose unchanged between 2 and 12 months after ligation in rabbits. This difference may be due to differences in breed and experimental conditions. In mini-pigs, pancreatic occlusion was not found to lead to glycemic disorders until 9 months, I351 whereas in rats, an increase in glycemia was described 5 to 8 months after ligation. I361 The comparative variations in glycemia and insulinemia of the C and PDL rabbits are illustrated in Figures la,b . During the 1st month, the elevated glucose levels in the C group could be explained by the effects of the anesthesia and laparotomy followed by operative stress, as described in fasting sham rats. [37] The hyperglycemia in the PDL group was more marked than that found in previous data [111 with a maximum (15.1 + 1.2mmol/1) that correlated (r= -0.94, p < 0.001) with the nadir in insulin levels (42 +__ 8pmol/1) on day 30 (Fig. lb) . The plasma insulin and the insulin pancreatic store (200 + 7g/total pancreas) (Fig. 2) From the 90th day, in the PDL group, glucose returned to its basal level, which was slightly higher than in the C group (Fig. la) . At the same time, the basal plasma insulin did not differ significantly from that in the C group (Fig. lb) (Fig. lc) . The basal plasma glucagon of 158 _ 15 ng/1 in the C group remained relatively stable over 450 days. It ranges from 120pg/ml in humans I181 and 180pg/ml in dogs I411 to 323 pg/ml and 331pg/ml in Wistar and GK rats, respectively (1). In contrast, our rabbits exhibited two significant hyperglucagonemic states (Fig. lc) after PDL. The first, from 15 to 60 days appeared with a peak (232 +-21.0ng/1, p < 0.01) at day 30. Immunocytochemical observations I141 have shown that as the B-cells are destroyed by the 30th day, the A-cells are preserved with hypertrophy of their nuclear areas, which is a reflection of hyperactivity. Moreover, the lack of alteration in pancreatic glucagon stores (Fig. 2) indicated that the A-cells released rather than stored glucagon. Their hyperactivity was probably the consequence of a loss of glucagoninhibiting action from the dispersal of B-and D-cells in fibrotic tissue. [42'43] A hyperglucagonemic state had been reported in NIDDM patients, [44, 45] in diabetic rats, [46] dogs, [47] and db/db mice. I481 In contrast to fetuses, adult GK rats Ill and neonatal STZ diabetic rats, I381 basal plasma glucagon was found to be unchanged and even lower in mini-pigs after pancreatic occlusion. I351 The second hyperglucagonemic state (Fig. lc) between 390 days (225 25.4ng/1 , p < 0.01) and 450 days (199 20ng/1, p < 0.01) being about 50% higher than the levels in the C group, was consistent with the morphological changes in the regenerated cells illustrated in Figure 6 . There was an increase in number of immunostained A-cells, which formed a thick crown surrounding the clusters of B-cells called pseudo-islets.
[141 These features were most marked from 270 to 450 days (Figs. 6c,d ) and probably caused the increase in both glucagonemia and pancreatic glucagon content (3-fold at 450 days) (Fig. 2) . The ability of the A-cells to continuously synthesize glucagon by releasing and storing it, showed that the regenerated insular A-cells had escaped normal endocrine regulation in the pseudo-islets. The simultaneous decrease in B-cells and increase in A-cells after PDL were similar to the evolution of pancreatic islet cells in either spontaneous [49] or induced I501 type 2 diabetes. In our experimental model, these events could be attributed to glucagonoma accounting for the uncontrolled glucagon release giving rise to an irreversible diabetogenic effect, as noted in the course of NIDDM in man. I511 When comparing the long-term (from 0 to 450 days) plasma glucagon profile (Fig. lc) with glucose levels (Fig. la) , the insulinemia (Fig. lb) [53] leading to excessive hepatic glucose production. I541 There was another possible relationship between the second hyperglucagonemic episode (Fig. lc) at 340-450 days and the hyperglycemic one starting 50 days later (Fig. la) , without hypoinsulinemia (Fig. lb) (Fig. 3) . At 5 min, the insulin response appeared to decline markedly at 180 and 270-450 days (2-fold to 5-fold, respectively) (Fig. 4) (57) (58) , and with chronic pancreatitis. I31 The progressive reduction in insulin response after PDL is consistent with the immunocytological findings (Fig. 6) . At 180 days post-ligation (Fig. 6b) (Fig. 4) illustrated the insensitivity of B-cells in the pseudo-islets accompanied by a decrease in pancreatic insulin stores (about 4-fold vs. controls) (Fig. 2) . These observations indicated that the regenerated B-cell mass was unable to synthesize active insulin in response to stimulation and could not even maintain pancreatic stores (Fig. lb) . This deficit in insulin secretion in regenerated B-cells has also been described in Zucker diabetic fatty (ZDF) [59] and STZ rats. I61 As the glucagon response to the IVGTT in rabbits has not yet been described, these experiments (Fig. 5) supplied further information about A-cell function in the regenerated islets greatly enriched by A-cells (Figs. 6c,d ). In the C group, the glucagon profile was similar to that of humans I81 i.e., with an initial progressive fall up to 60 min followed by a significant increase at 90 min (Fig. 5 ). After PDL (Fig. 5) , by 180 days, the plasma glucagon response declined at 5 min as in controls, but there was a significant increase from 30 min (p < 0.05) to 60 min (p < 0.01). The same hyperglucagonemic profile has been described in diabetic dogs [41] after oral glucose administration. After PDL, on appearance of new islets near the original structure (Fig. 6b) , the glucose sensitivity of both A-anc B-cells was found to be less affected than at 270-450 days (Figs. 6c,d ). At these later periods, the nearly horizontal profile (Fig. 5) 
